Independent Portfolio Consultants’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$8K Hold
195
﹤0.01% 740
2017
Q1
$7K Sell
195
-75
-28% -$2.38K ﹤0.01% 777
2016
Q4
$8K Buy
270
+50
+23% +$1.55K ﹤0.01% 718
2016
Q3
$7K Sell
220
-55
-20% -$1.66K ﹤0.01% 696
2016
Q2
$8K Hold
275
﹤0.01% 712
2016
Q1
$7K Buy
275
+85
+45% +$2.08K ﹤0.01% 734
2015
Q4
$5K Hold
190
﹤0.01% 742
2015
Q3
$5K Buy
190
+135
+245% +$4.88K ﹤0.01% 764
2015
Q2
$2K Sell
55
-25
-31% -$916 ﹤0.01% 833
2015
Q1
$2K Sell
80
-25
-24% -$648 ﹤0.01% 881
2014
Q4
$2K Buy
+105
New +$2.35K ﹤0.01% 769

Other funds holding RGEN

Independent Portfolio Consultants's RGEN Position: Q2 2017 in Review

Independent Portfolio Consultants held its Repligen (RGEN) position steady in Q2 2017 at 195 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #740.

Independent Portfolio Consultants first reported a position in RGEN in Q4 2014 and has held it in 11 quarters since. 199 funds tracked by Wall St. Rank hold RGEN as of Q2 2017.

  • Independent Portfolio Consultants held 195 shares of Repligen worth $8K as of Q2 2017.
  • Independent Portfolio Consultants left its Repligen share count unchanged in Q2 2017.
  • Repligen made up ﹤0.01% of Independent Portfolio Consultants's portfolio in Q2 2017, its #740 holding.
  • Independent Portfolio Consultants first reported a position in Repligen in Q4 2014 and has held it in 11 quarters since.
  • 199 funds tracked by Wall St. Rank held Repligen as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.